Skip to Content
You are currently on the new version of our website. Access the old version .
Marine DrugsMarine Drugs
  • Article
  • Open Access

12 December 2019

9 Pages

Enhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium Enhygromyxa sp.

,
,
,
and
1
Pharmaceutical Sciences Division, University of Wisconsin–Madison, Madison, WI 53705, USA
2
Sea Samples, 369 Westshore Drive, Summerland Key, FL 33042, USA
*
Author to whom correspondence should be addressed.

Abstract

To date, studies describing myxobacterial secondary metabolites have been relatively scarce in comparison to those addressing actinobacterial secondary metabolites. This realization suggests the immense potential of myxobacteria as an intriguing source of secondary metabolites with unusual structural features and a wide array of biological activities. Marine-derived myxobacteria are especially attractive due to their unique biosynthetic gene clusters, although they are more difficult to handle than terrestrial myxobacteria. Here, we report the discovery of two new pyrazinone-type molecules, enhypyrazinones A and B, from a marine-derived myxobacterium Enhygromyxa sp. Their structures were elucidated by HRESIMS and comprehensive NMR data analyses. Compounds 1 and 2, which contain a rare trisubstituted-pyrazinone core, represent a unique class of molecules from Enhygromyxa sp.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.